Olfactory dysfunction as an early predictor for post‐COVID condition at 1‐year follow‐up
Brain and Behavior · 2024-06 · 14 (6)
DOI: 10.1002/brb3.3574 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain and Behavior, online erschienen am 06.06.2024. Verfasst von Christoffer Granvik und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Microbiology, Umeå University, Umeå, Sweden. Hauptthemen laut MEDLINE: COVID-19, Olfaction Disorders, Quality of Life, Neuropsychological Tests. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Research Council, Hjärt-Lungfonden, Knut och Alice Wallenbergs Stiftelse.
Abstract (Originalsprache)
Background
Olfactory dysfunction together with neurological and cognitive symptoms are common after COVID‐19. We aimed to study whether performance on olfactory and neuropsychological tests following infection predict post‐COVID condition (PCC), persisting symptoms, and reduced health‐related quality of life.
Methods
Both hospitalized (N = 10) and non‐hospitalized individuals (N = 56) were enrolled in this prospective cohort study. Participants were evaluated 1–3 months after infection with an olfactory threshold test and neuropsychological tests, which was used as predictors of PCC. A questionnaire outlining persisting symptoms and the validated instrument EuroQol five‐dimension five‐level for health‐related quality of life assessment were used as outcome data 1 year after infection (N = 59). Principal component analysis was used to identify relevant predictors for PCC at 1 year.
Results
Objectively assessed olfactory dysfunction at 1–3 months post infection, but not subjective olfactory symptoms, predicted post‐COVID condition with reduced health‐related quality of life (PCC+) at 1 year. The PCC+ group scored more often below the cut off for mild cognitive impairment on the Montreal Cognitive Assessment (61.5% vs. 21.7%) and higher on the Multidimensional Fatigue Inventory‐20, compared to the group without PCC+.
Conclusion
Our results indicate that objectively assessed, olfactory dysfunction is a predictor for PCC+. These findings underscore the importance of objective olfactory testing. We propose that olfactory screening in the early post‐acute phase of COVID‐19 infection might identify individuals that are at higher risk of developing long‐term health sequalae.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Microbiology, Umeå University, Umeå, Sweden.
- Department of Integrative Medical Biology, Umeå University, Umeå, Sweden.
- Department of Psychology, Umeå University, Umeå, Sweden.
- Department of Diagnostics and Intervention, Umeå University, Umeå, Sweden.
ORCID-Profile: Alicia Edin
Förderung
- Swedish Research Council
- Hjärt-Lungfonden
- Knut och Alice Wallenbergs Stiftelse
- County Council of Västerbotten
- Vetenskapsrådet
Zitieren
APA
Granvik, C., Andersson, S., Andersson, L., Brorsson, C., Forsell, M., Ahlm, C., Normark, J., & Edin, A. (2024). Olfactory dysfunction as an early predictor for post‐COVID condition at 1‐year follow‐up. Brain and Behavior, 14(6). https://doi.org/10.1002/brb3.3574
Vancouver
Granvik C, Andersson S, Andersson L, Brorsson C, Forsell M, Ahlm C, et al. Olfactory dysfunction as an early predictor for post‐COVID condition at 1‐year follow‐up. Brain and Behavior. 2024;14(6). doi:10.1002/brb3.3574
BibTeX
@article{Granvik2024,
author = {Granvik, Christoffer and Andersson, Sara and Andersson, Linus and Brorsson, Camilla and Forsell, Mattias and Ahlm, Clas and Normark, Johan and Edin, Alicia},
title = {Olfactory dysfunction as an early predictor for post‐COVID condition at 1‐year follow‐up},
journal = {Brain and Behavior},
year = {2024},
volume = {14},
number = {6},
doi = {10.1002/brb3.3574}
}
EUVIMED